ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,215
Screening encounters
2,403
Diagnostic referrals
462
Outstanding pathways
195

Screening pathway

  1. Screening2,403Encounters
  2. Positive finding805Documented findings
  3. Referral462Diagnostic referrals
  4. Follow-up515Diagnostic visits
  5. Outcome267Resolved pathways

Stage totals use different units. Pending pathways: 195. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 3631 · EXP-3631Synthetic · Site B

Full participant history through 2026-01-26, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-07-24
  4. · Diagnostic referral · EXP-3631-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Transport difficulty
  8. · Navigation intervention · Coordination support
  9. · Diagnostic visit · Attended
  10. · Diagnosis · Colposcopy · Biopsy collected
  11. · Diagnosis · Histopathology · No high-grade lesion identified
  12. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-03-21
  13. · Follow-up disposition · Resolved · EXP-3631-T-R
  14. · Screening · HPV DNA · Repeat · Prior VIA positive
  15. · Screening result · HPV DNA · HPV not detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

2215 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-3556 · Expanded synthetic participant 3556Site A — Urban Referral Hub
EXP-3557 · Expanded synthetic participant 3557Site C — Rural Outreach Programme
EXP-3558 · Expanded synthetic participant 3558Site A — Urban Referral Hub
EXP-3559 · Expanded synthetic participant 3559Site D — Community Engagement Programme
EXP-3563 · Expanded synthetic participant 3563Site C — Rural Outreach Programme
EXP-3564 · Expanded synthetic participant 3564Site D — Community Engagement Programme
EXP-3565 · Expanded synthetic participant 3565Site A — Urban Referral Hub
EXP-3567 · Expanded synthetic participant 3567Site A — Urban Referral Hub
EXP-3568 · Expanded synthetic participant 3568Site D — Community Engagement Programme
EXP-3570 · Expanded synthetic participant 3570Site B — Peri-Urban Access Programme
EXP-3573 · Expanded synthetic participant 3573Site B — Peri-Urban Access Programme
EXP-3574 · Expanded synthetic participant 3574Site A — Urban Referral Hub
EXP-3575 · Expanded synthetic participant 3575Site E — Resource-Constrained Navigation Programme
EXP-3576 · Expanded synthetic participant 3576Site E — Resource-Constrained Navigation Programme
EXP-3580 · Expanded synthetic participant 3580Site A — Urban Referral Hub
EXP-3582 · Expanded synthetic participant 3582Site C — Rural Outreach Programme
EXP-3584 · Expanded synthetic participant 3584Site A — Urban Referral Hub
EXP-3585 · Expanded synthetic participant 3585Site E — Resource-Constrained Navigation Programme
EXP-3587 · Expanded synthetic participant 3587Site A — Urban Referral Hub
EXP-3588 · Expanded synthetic participant 3588Site C — Rural Outreach Programme
EXP-3591 · Expanded synthetic participant 3591Site B — Peri-Urban Access Programme
EXP-3592 · Expanded synthetic participant 3592Site E — Resource-Constrained Navigation Programme
EXP-3594 · Expanded synthetic participant 3594Site B — Peri-Urban Access Programme
EXP-3597 · Expanded synthetic participant 3597Site E — Resource-Constrained Navigation Programme
EXP-3601 · Expanded synthetic participant 3601Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1008
HPV DNA
1037
Cytology
358

Navigation activity

Barrier documented
397
Contact attempt
679
Navigation intervention
164
Diagnostic booking
572
Diagnostic visit
515

Documented barriers

Contact difficulty
125
Transport difficulty
133
Appointment coordination
139

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.